Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Preventing Ventilation-Induced Lung Injury

By HospiMedica staff writers
Posted on 15 Aug 2006
A new study of mice has found that pumping too much air into the lung over-distends the organ, leading to ventilator-induced lung injury (VILI).

Researchers from the University of Vermont (Burlington, VT, USA) divided mice into three experimental groups. More...
All three groups received positive end-expiratory pressure (PEEP) and low tidal volume air. Each group was ventilated for two hours. The experimental groups differed according to how many deep inflations they received: HV (high volume) received one deep inflation each breath; LV (low volume) received two deep inflations each hour; LVDI (low volume deep inflation) received two deep inflations each minute. In addition, there were two control groups: a surgical sham, which received no ventilation, and a group that received deep inflation every breath and no PEEP.

The study found that the lungs of the mice given LVDI remained more open and functioned better than the LV and HV. The lungs of the mice that received only LV became stiff and portions of the lungs collapsed. However, lung function returned briefly to normal when the mice received their infrequent deep inflations. This suggests that the lungs self-repair after the deep inflation, at least over the course of the first two hours.

The lungs of the mice that received HV suffered overdistention injury to their lungs. This group was similar to a high tidal volume group, once again demonstrating that low tidal volume is safer. The control group that received high tidal volume but no PEEP showed the highest evidence of injury, even higher than the high tidal volume group. This indicates that PEEP helps reduce the negative effects of frequent deep inflation. The study was published in the May 12, 2006, online edition of the American Journal of Physiology-Lung Cellular and Molecular Physiology.

"There is still a lot of controversy and uncertainty about how best to ventilate the lung,” said lead author, Dr. Jason HT Bates. "One controversy is whether deep inflations, the ‘sighs' that each of us takes periodically, should ever be given, and if so, how frequently. We demonstrated it's possible to give deep breaths too frequently and too seldom.”



Related Links:
University of Vermont

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.